nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—Diplopia—Doxorubicin—muscle cancer	0.00165	0.00165	CcSEcCtD
Methylphenidate—Asthma—Methotrexate—muscle cancer	0.00164	0.00164	CcSEcCtD
Methylphenidate—Chest pain—Etoposide—muscle cancer	0.00163	0.00163	CcSEcCtD
Methylphenidate—Affect lability—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Methylphenidate—Migraine—Doxorubicin—muscle cancer	0.00162	0.00162	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	0.00162	0.00162	CcSEcCtD
Methylphenidate—Pancreatitis—Methotrexate—muscle cancer	0.00161	0.00161	CcSEcCtD
Methylphenidate—Discomfort—Etoposide—muscle cancer	0.00161	0.00161	CcSEcCtD
Methylphenidate—Hypersensitivity—Dactinomycin—muscle cancer	0.00159	0.00159	CcSEcCtD
Methylphenidate—Abdominal discomfort—Methotrexate—muscle cancer	0.00157	0.00157	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Vincristine—muscle cancer	0.00157	0.00157	CcSEcCtD
Methylphenidate—Confusional state—Etoposide—muscle cancer	0.00157	0.00157	CcSEcCtD
Methylphenidate—Cardiac arrest—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Methylphenidate—Pancytopenia—Methotrexate—muscle cancer	0.00156	0.00156	CcSEcCtD
Methylphenidate—Anaphylactic shock—Etoposide—muscle cancer	0.00156	0.00156	CcSEcCtD
Methylphenidate—Mood swings—Doxorubicin—muscle cancer	0.00156	0.00156	CcSEcCtD
Methylphenidate—Infection—Etoposide—muscle cancer	0.00155	0.00155	CcSEcCtD
Methylphenidate—Asthenia—Dactinomycin—muscle cancer	0.00155	0.00155	CcSEcCtD
Methylphenidate—Dehydration—Doxorubicin—muscle cancer	0.00153	0.00153	CcSEcCtD
Methylphenidate—Thrombocytopenia—Etoposide—muscle cancer	0.00153	0.00153	CcSEcCtD
Methylphenidate—Upper respiratory tract infection—Methotrexate—muscle cancer	0.00153	0.00153	CcSEcCtD
Methylphenidate—Tachycardia—Etoposide—muscle cancer	0.00152	0.00152	CcSEcCtD
Methylphenidate—Abdominal pain—Vincristine—muscle cancer	0.00152	0.00152	CcSEcCtD
Methylphenidate—Body temperature increased—Vincristine—muscle cancer	0.00152	0.00152	CcSEcCtD
Methylphenidate—Liver function test abnormal—Doxorubicin—muscle cancer	0.00152	0.00152	CcSEcCtD
Methylphenidate—Skin disorder—Etoposide—muscle cancer	0.00151	0.00151	CcSEcCtD
Methylphenidate—Erectile dysfunction—Methotrexate—muscle cancer	0.00151	0.00151	CcSEcCtD
Methylphenidate—Hyperhidrosis—Etoposide—muscle cancer	0.00151	0.00151	CcSEcCtD
Methylphenidate—Abdominal pain upper—Doxorubicin—muscle cancer	0.0015	0.0015	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Methotrexate—muscle cancer	0.0015	0.0015	CcSEcCtD
Methylphenidate—Breast disorder—Doxorubicin—muscle cancer	0.00149	0.00149	CcSEcCtD
Methylphenidate—Anorexia—Etoposide—muscle cancer	0.00149	0.00149	CcSEcCtD
Methylphenidate—Diarrhoea—Dactinomycin—muscle cancer	0.00147	0.00147	CcSEcCtD
Methylphenidate—Pneumonia—Methotrexate—muscle cancer	0.00147	0.00147	CcSEcCtD
Methylphenidate—Nasopharyngitis—Doxorubicin—muscle cancer	0.00147	0.00147	CcSEcCtD
Methylphenidate—Infestation—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Methylphenidate—Infestation NOS—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Methylphenidate—Drowsiness—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Methylphenidate—Depression—Methotrexate—muscle cancer	0.00146	0.00146	CcSEcCtD
Methylphenidate—Gastritis—Doxorubicin—muscle cancer	0.00146	0.00146	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Methotrexate—muscle cancer	0.00145	0.00145	CcSEcCtD
Methylphenidate—Alanine aminotransferase increased—Doxorubicin—muscle cancer	0.00145	0.00145	CcSEcCtD
Methylphenidate—Conjunctivitis—Methotrexate—muscle cancer	0.00142	0.00142	CcSEcCtD
Methylphenidate—Influenza—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Methylphenidate—Asthma—Doxorubicin—muscle cancer	0.00142	0.00142	CcSEcCtD
Methylphenidate—Hypersensitivity—Vincristine—muscle cancer	0.00142	0.00142	CcSEcCtD
Methylphenidate—Sweating—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Methylphenidate—Paraesthesia—Etoposide—muscle cancer	0.0014	0.0014	CcSEcCtD
Methylphenidate—Haematuria—Methotrexate—muscle cancer	0.0014	0.0014	CcSEcCtD
Methylphenidate—Pancreatitis—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Methylphenidate—Dyspnoea—Etoposide—muscle cancer	0.00139	0.00139	CcSEcCtD
Methylphenidate—Somnolence—Etoposide—muscle cancer	0.00139	0.00139	CcSEcCtD
Methylphenidate—Angina pectoris—Doxorubicin—muscle cancer	0.00139	0.00139	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Methylphenidate—Epistaxis—Methotrexate—muscle cancer	0.00138	0.00138	CcSEcCtD
Methylphenidate—Asthenia—Vincristine—muscle cancer	0.00138	0.00138	CcSEcCtD
Methylphenidate—Vomiting—Dactinomycin—muscle cancer	0.00137	0.00137	CcSEcCtD
Methylphenidate—Bronchitis—Doxorubicin—muscle cancer	0.00137	0.00137	CcSEcCtD
Methylphenidate—Rash—Dactinomycin—muscle cancer	0.00136	0.00136	CcSEcCtD
Methylphenidate—Decreased appetite—Etoposide—muscle cancer	0.00136	0.00136	CcSEcCtD
Methylphenidate—Pancytopenia—Doxorubicin—muscle cancer	0.00135	0.00135	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Etoposide—muscle cancer	0.00135	0.00135	CcSEcCtD
Methylphenidate—Fatigue—Etoposide—muscle cancer	0.00134	0.00134	CcSEcCtD
Methylphenidate—Pain—Etoposide—muscle cancer	0.00133	0.00133	CcSEcCtD
Methylphenidate—Constipation—Etoposide—muscle cancer	0.00133	0.00133	CcSEcCtD
Methylphenidate—Upper respiratory tract infection—Doxorubicin—muscle cancer	0.00132	0.00132	CcSEcCtD
Methylphenidate—Haemoglobin—Methotrexate—muscle cancer	0.00132	0.00132	CcSEcCtD
Methylphenidate—Diarrhoea—Vincristine—muscle cancer	0.00132	0.00132	CcSEcCtD
Methylphenidate—Haemorrhage—Methotrexate—muscle cancer	0.00131	0.00131	CcSEcCtD
Methylphenidate—Pharyngitis—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Methylphenidate—Urinary tract disorder—Methotrexate—muscle cancer	0.0013	0.0013	CcSEcCtD
Methylphenidate—Photosensitivity reaction—Doxorubicin—muscle cancer	0.0013	0.0013	CcSEcCtD
Methylphenidate—Weight increased—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Methylphenidate—Urethral disorder—Methotrexate—muscle cancer	0.00129	0.00129	CcSEcCtD
Methylphenidate—Weight decreased—Doxorubicin—muscle cancer	0.00129	0.00129	CcSEcCtD
Methylphenidate—Feeling abnormal—Etoposide—muscle cancer	0.00128	0.00128	CcSEcCtD
Methylphenidate—Nausea—Dactinomycin—muscle cancer	0.00128	0.00128	CcSEcCtD
Methylphenidate—Pneumonia—Doxorubicin—muscle cancer	0.00128	0.00128	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Etoposide—muscle cancer	0.00127	0.00127	CcSEcCtD
Methylphenidate—Dizziness—Vincristine—muscle cancer	0.00127	0.00127	CcSEcCtD
Methylphenidate—Infestation—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Methylphenidate—Infestation NOS—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Methylphenidate—Drowsiness—Doxorubicin—muscle cancer	0.00127	0.00127	CcSEcCtD
Methylphenidate—Visual impairment—Methotrexate—muscle cancer	0.00127	0.00127	CcSEcCtD
Methylphenidate—Stevens-Johnson syndrome—Doxorubicin—muscle cancer	0.00126	0.00126	CcSEcCtD
Methylphenidate—Erythema multiforme—Methotrexate—muscle cancer	0.00124	0.00124	CcSEcCtD
Methylphenidate—Urticaria—Etoposide—muscle cancer	0.00124	0.00124	CcSEcCtD
Methylphenidate—Body temperature increased—Etoposide—muscle cancer	0.00123	0.00123	CcSEcCtD
Methylphenidate—Abdominal pain—Etoposide—muscle cancer	0.00123	0.00123	CcSEcCtD
Methylphenidate—Conjunctivitis—Doxorubicin—muscle cancer	0.00123	0.00123	CcSEcCtD
Methylphenidate—Eye disorder—Methotrexate—muscle cancer	0.00123	0.00123	CcSEcCtD
Methylphenidate—Vomiting—Vincristine—muscle cancer	0.00122	0.00122	CcSEcCtD
Methylphenidate—Cardiac disorder—Methotrexate—muscle cancer	0.00122	0.00122	CcSEcCtD
Methylphenidate—Sweating—Doxorubicin—muscle cancer	0.00122	0.00122	CcSEcCtD
Methylphenidate—Rash—Vincristine—muscle cancer	0.00121	0.00121	CcSEcCtD
Methylphenidate—Dermatitis—Vincristine—muscle cancer	0.00121	0.00121	CcSEcCtD
Methylphenidate—Haematuria—Doxorubicin—muscle cancer	0.00121	0.00121	CcSEcCtD
Methylphenidate—Headache—Vincristine—muscle cancer	0.00121	0.00121	CcSEcCtD
Methylphenidate—Hepatobiliary disease—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Methylphenidate—Epistaxis—Doxorubicin—muscle cancer	0.0012	0.0012	CcSEcCtD
Methylphenidate—Angiopathy—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Methylphenidate—Sinusitis—Doxorubicin—muscle cancer	0.00119	0.00119	CcSEcCtD
Methylphenidate—Immune system disorder—Methotrexate—muscle cancer	0.00119	0.00119	CcSEcCtD
Methylphenidate—Mediastinal disorder—Methotrexate—muscle cancer	0.00118	0.00118	CcSEcCtD
Methylphenidate—Chills—Methotrexate—muscle cancer	0.00118	0.00118	CcSEcCtD
Methylphenidate—Alopecia—Methotrexate—muscle cancer	0.00116	0.00116	CcSEcCtD
Methylphenidate—Bradycardia—Doxorubicin—muscle cancer	0.00116	0.00116	CcSEcCtD
Methylphenidate—Mental disorder—Methotrexate—muscle cancer	0.00115	0.00115	CcSEcCtD
Methylphenidate—Hypersensitivity—Etoposide—muscle cancer	0.00115	0.00115	CcSEcCtD
Methylphenidate—Malnutrition—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Methylphenidate—Erythema—Methotrexate—muscle cancer	0.00114	0.00114	CcSEcCtD
Methylphenidate—Haemoglobin—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Methylphenidate—Nausea—Vincristine—muscle cancer	0.00114	0.00114	CcSEcCtD
Methylphenidate—Rhinitis—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Methylphenidate—Haemorrhage—Doxorubicin—muscle cancer	0.00114	0.00114	CcSEcCtD
Methylphenidate—Pharyngitis—Doxorubicin—muscle cancer	0.00113	0.00113	CcSEcCtD
Methylphenidate—Urinary tract disorder—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Methylphenidate—Asthenia—Etoposide—muscle cancer	0.00112	0.00112	CcSEcCtD
Methylphenidate—Connective tissue disorder—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Methylphenidate—Urethral disorder—Doxorubicin—muscle cancer	0.00112	0.00112	CcSEcCtD
Methylphenidate—Back pain—Methotrexate—muscle cancer	0.00111	0.00111	CcSEcCtD
Methylphenidate—Pruritus—Etoposide—muscle cancer	0.0011	0.0011	CcSEcCtD
Methylphenidate—Visual impairment—Doxorubicin—muscle cancer	0.0011	0.0011	CcSEcCtD
Methylphenidate—Vision blurred—Methotrexate—muscle cancer	0.00108	0.00108	CcSEcCtD
Methylphenidate—Erythema multiforme—Doxorubicin—muscle cancer	0.00108	0.00108	CcSEcCtD
Methylphenidate—Diarrhoea—Etoposide—muscle cancer	0.00107	0.00107	CcSEcCtD
Methylphenidate—Eye disorder—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Methylphenidate—Ill-defined disorder—Methotrexate—muscle cancer	0.00106	0.00106	CcSEcCtD
Methylphenidate—Anaemia—Methotrexate—muscle cancer	0.00106	0.00106	CcSEcCtD
Methylphenidate—Flushing—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Methylphenidate—Cardiac disorder—Doxorubicin—muscle cancer	0.00106	0.00106	CcSEcCtD
Methylphenidate—Angiopathy—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Methylphenidate—Malaise—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Methylphenidate—Dizziness—Etoposide—muscle cancer	0.00103	0.00103	CcSEcCtD
Methylphenidate—Immune system disorder—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Methylphenidate—Vertigo—Methotrexate—muscle cancer	0.00103	0.00103	CcSEcCtD
Methylphenidate—Mediastinal disorder—Doxorubicin—muscle cancer	0.00103	0.00103	CcSEcCtD
Methylphenidate—Leukopenia—Methotrexate—muscle cancer	0.00102	0.00102	CcSEcCtD
Methylphenidate—Chills—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Methylphenidate—Arrhythmia—Doxorubicin—muscle cancer	0.00102	0.00102	CcSEcCtD
Methylphenidate—Alopecia—Doxorubicin—muscle cancer	0.00101	0.00101	CcSEcCtD
Methylphenidate—Cough—Methotrexate—muscle cancer	0.000999	0.000999	CcSEcCtD
Methylphenidate—Mental disorder—Doxorubicin—muscle cancer	0.000997	0.000997	CcSEcCtD
Methylphenidate—Convulsion—Methotrexate—muscle cancer	0.000991	0.000991	CcSEcCtD
Methylphenidate—Vomiting—Etoposide—muscle cancer	0.000991	0.000991	CcSEcCtD
Methylphenidate—Malnutrition—Doxorubicin—muscle cancer	0.000991	0.000991	CcSEcCtD
Methylphenidate—Erythema—Doxorubicin—muscle cancer	0.000991	0.000991	CcSEcCtD
Methylphenidate—Rash—Etoposide—muscle cancer	0.000983	0.000983	CcSEcCtD
Methylphenidate—Dermatitis—Etoposide—muscle cancer	0.000982	0.000982	CcSEcCtD
Methylphenidate—Headache—Etoposide—muscle cancer	0.000977	0.000977	CcSEcCtD
Methylphenidate—Arthralgia—Methotrexate—muscle cancer	0.000974	0.000974	CcSEcCtD
Methylphenidate—Myalgia—Methotrexate—muscle cancer	0.000974	0.000974	CcSEcCtD
Methylphenidate—Chest pain—Methotrexate—muscle cancer	0.000974	0.000974	CcSEcCtD
Methylphenidate—Tension—Doxorubicin—muscle cancer	0.000972	0.000972	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	0.000967	0.000967	CcSEcCtD
Methylphenidate—Discomfort—Methotrexate—muscle cancer	0.000963	0.000963	CcSEcCtD
Methylphenidate—Nervousness—Doxorubicin—muscle cancer	0.000962	0.000962	CcSEcCtD
Methylphenidate—Back pain—Doxorubicin—muscle cancer	0.000958	0.000958	CcSEcCtD
Methylphenidate—Muscle spasms—Doxorubicin—muscle cancer	0.000953	0.000953	CcSEcCtD
Methylphenidate—Confusional state—Methotrexate—muscle cancer	0.000942	0.000942	CcSEcCtD
Methylphenidate—Anaphylactic shock—Methotrexate—muscle cancer	0.000934	0.000934	CcSEcCtD
Methylphenidate—Vision blurred—Doxorubicin—muscle cancer	0.000934	0.000934	CcSEcCtD
Methylphenidate—Infection—Methotrexate—muscle cancer	0.000928	0.000928	CcSEcCtD
Methylphenidate—Nausea—Etoposide—muscle cancer	0.000926	0.000926	CcSEcCtD
Methylphenidate—Ill-defined disorder—Doxorubicin—muscle cancer	0.000919	0.000919	CcSEcCtD
Methylphenidate—Nervous system disorder—Methotrexate—muscle cancer	0.000916	0.000916	CcSEcCtD
Methylphenidate—Anaemia—Doxorubicin—muscle cancer	0.000916	0.000916	CcSEcCtD
Methylphenidate—Thrombocytopenia—Methotrexate—muscle cancer	0.000914	0.000914	CcSEcCtD
Methylphenidate—Agitation—Doxorubicin—muscle cancer	0.000911	0.000911	CcSEcCtD
Methylphenidate—Skin disorder—Methotrexate—muscle cancer	0.000907	0.000907	CcSEcCtD
Methylphenidate—Hyperhidrosis—Methotrexate—muscle cancer	0.000903	0.000903	CcSEcCtD
Methylphenidate—Malaise—Doxorubicin—muscle cancer	0.000894	0.000894	CcSEcCtD
Methylphenidate—Vertigo—Doxorubicin—muscle cancer	0.00089	0.00089	CcSEcCtD
Methylphenidate—Anorexia—Methotrexate—muscle cancer	0.00089	0.00089	CcSEcCtD
Methylphenidate—Syncope—Doxorubicin—muscle cancer	0.000889	0.000889	CcSEcCtD
Methylphenidate—Leukopenia—Doxorubicin—muscle cancer	0.000887	0.000887	CcSEcCtD
Methylphenidate—Palpitations—Doxorubicin—muscle cancer	0.000876	0.000876	CcSEcCtD
Methylphenidate—Loss of consciousness—Doxorubicin—muscle cancer	0.000871	0.000871	CcSEcCtD
Methylphenidate—Cough—Doxorubicin—muscle cancer	0.000865	0.000865	CcSEcCtD
Methylphenidate—Convulsion—Doxorubicin—muscle cancer	0.000858	0.000858	CcSEcCtD
Methylphenidate—Hypertension—Doxorubicin—muscle cancer	0.000855	0.000855	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Methotrexate—muscle cancer	0.000851	0.000851	CcSEcCtD
Methylphenidate—Insomnia—Methotrexate—muscle cancer	0.000845	0.000845	CcSEcCtD
Methylphenidate—Arthralgia—Doxorubicin—muscle cancer	0.000844	0.000844	CcSEcCtD
Methylphenidate—Myalgia—Doxorubicin—muscle cancer	0.000844	0.000844	CcSEcCtD
Methylphenidate—Chest pain—Doxorubicin—muscle cancer	0.000844	0.000844	CcSEcCtD
Methylphenidate—Anxiety—Doxorubicin—muscle cancer	0.000841	0.000841	CcSEcCtD
Methylphenidate—Paraesthesia—Methotrexate—muscle cancer	0.000839	0.000839	CcSEcCtD
Methylphenidate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	0.000838	0.000838	CcSEcCtD
Methylphenidate—Discomfort—Doxorubicin—muscle cancer	0.000833	0.000833	CcSEcCtD
Methylphenidate—Dyspnoea—Methotrexate—muscle cancer	0.000833	0.000833	CcSEcCtD
Methylphenidate—Somnolence—Methotrexate—muscle cancer	0.00083	0.00083	CcSEcCtD
Methylphenidate—Dry mouth—Doxorubicin—muscle cancer	0.000825	0.000825	CcSEcCtD
Methylphenidate—Dyspepsia—Methotrexate—muscle cancer	0.000822	0.000822	CcSEcCtD
Methylphenidate—Confusional state—Doxorubicin—muscle cancer	0.000815	0.000815	CcSEcCtD
Methylphenidate—Decreased appetite—Methotrexate—muscle cancer	0.000812	0.000812	CcSEcCtD
Methylphenidate—Anaphylactic shock—Doxorubicin—muscle cancer	0.000809	0.000809	CcSEcCtD
Methylphenidate—Oedema—Doxorubicin—muscle cancer	0.000809	0.000809	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Methotrexate—muscle cancer	0.000806	0.000806	CcSEcCtD
Methylphenidate—Fatigue—Methotrexate—muscle cancer	0.000805	0.000805	CcSEcCtD
Methylphenidate—Infection—Doxorubicin—muscle cancer	0.000803	0.000803	CcSEcCtD
Methylphenidate—Pain—Methotrexate—muscle cancer	0.000799	0.000799	CcSEcCtD
Methylphenidate—Shock—Doxorubicin—muscle cancer	0.000796	0.000796	CcSEcCtD
Methylphenidate—Nervous system disorder—Doxorubicin—muscle cancer	0.000793	0.000793	CcSEcCtD
Methylphenidate—Thrombocytopenia—Doxorubicin—muscle cancer	0.000792	0.000792	CcSEcCtD
Methylphenidate—Tachycardia—Doxorubicin—muscle cancer	0.000789	0.000789	CcSEcCtD
Methylphenidate—Skin disorder—Doxorubicin—muscle cancer	0.000785	0.000785	CcSEcCtD
Methylphenidate—Hyperhidrosis—Doxorubicin—muscle cancer	0.000782	0.000782	CcSEcCtD
Methylphenidate—Anorexia—Doxorubicin—muscle cancer	0.000771	0.000771	CcSEcCtD
Methylphenidate—Feeling abnormal—Methotrexate—muscle cancer	0.00077	0.00077	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Methotrexate—muscle cancer	0.000764	0.000764	CcSEcCtD
Methylphenidate—Urticaria—Methotrexate—muscle cancer	0.000742	0.000742	CcSEcCtD
Methylphenidate—Abdominal pain—Methotrexate—muscle cancer	0.000738	0.000738	CcSEcCtD
Methylphenidate—Body temperature increased—Methotrexate—muscle cancer	0.000738	0.000738	CcSEcCtD
Methylphenidate—Musculoskeletal discomfort—Doxorubicin—muscle cancer	0.000737	0.000737	CcSEcCtD
Methylphenidate—Insomnia—Doxorubicin—muscle cancer	0.000731	0.000731	CcSEcCtD
Methylphenidate—Paraesthesia—Doxorubicin—muscle cancer	0.000726	0.000726	CcSEcCtD
Methylphenidate—Dyspnoea—Doxorubicin—muscle cancer	0.000721	0.000721	CcSEcCtD
Methylphenidate—Somnolence—Doxorubicin—muscle cancer	0.000719	0.000719	CcSEcCtD
Methylphenidate—Dyspepsia—Doxorubicin—muscle cancer	0.000712	0.000712	CcSEcCtD
Methylphenidate—Decreased appetite—Doxorubicin—muscle cancer	0.000703	0.000703	CcSEcCtD
Methylphenidate—Gastrointestinal disorder—Doxorubicin—muscle cancer	0.000698	0.000698	CcSEcCtD
Methylphenidate—Fatigue—Doxorubicin—muscle cancer	0.000697	0.000697	CcSEcCtD
Methylphenidate—Pain—Doxorubicin—muscle cancer	0.000692	0.000692	CcSEcCtD
Methylphenidate—Constipation—Doxorubicin—muscle cancer	0.000692	0.000692	CcSEcCtD
Methylphenidate—Hypersensitivity—Methotrexate—muscle cancer	0.000688	0.000688	CcSEcCtD
Methylphenidate—Asthenia—Methotrexate—muscle cancer	0.00067	0.00067	CcSEcCtD
Methylphenidate—Feeling abnormal—Doxorubicin—muscle cancer	0.000666	0.000666	CcSEcCtD
Methylphenidate—Gastrointestinal pain—Doxorubicin—muscle cancer	0.000661	0.000661	CcSEcCtD
Methylphenidate—Pruritus—Methotrexate—muscle cancer	0.000661	0.000661	CcSEcCtD
Methylphenidate—Urticaria—Doxorubicin—muscle cancer	0.000642	0.000642	CcSEcCtD
Methylphenidate—Body temperature increased—Doxorubicin—muscle cancer	0.000639	0.000639	CcSEcCtD
Methylphenidate—Abdominal pain—Doxorubicin—muscle cancer	0.000639	0.000639	CcSEcCtD
Methylphenidate—Diarrhoea—Methotrexate—muscle cancer	0.000639	0.000639	CcSEcCtD
Methylphenidate—Dizziness—Methotrexate—muscle cancer	0.000618	0.000618	CcSEcCtD
Methylphenidate—Hypersensitivity—Doxorubicin—muscle cancer	0.000596	0.000596	CcSEcCtD
Methylphenidate—Vomiting—Methotrexate—muscle cancer	0.000594	0.000594	CcSEcCtD
Methylphenidate—Rash—Methotrexate—muscle cancer	0.000589	0.000589	CcSEcCtD
Methylphenidate—Dermatitis—Methotrexate—muscle cancer	0.000588	0.000588	CcSEcCtD
Methylphenidate—Headache—Methotrexate—muscle cancer	0.000585	0.000585	CcSEcCtD
Methylphenidate—Asthenia—Doxorubicin—muscle cancer	0.00058	0.00058	CcSEcCtD
Methylphenidate—Pruritus—Doxorubicin—muscle cancer	0.000572	0.000572	CcSEcCtD
Methylphenidate—Nausea—Methotrexate—muscle cancer	0.000555	0.000555	CcSEcCtD
Methylphenidate—Diarrhoea—Doxorubicin—muscle cancer	0.000553	0.000553	CcSEcCtD
Methylphenidate—Dizziness—Doxorubicin—muscle cancer	0.000535	0.000535	CcSEcCtD
Methylphenidate—Vomiting—Doxorubicin—muscle cancer	0.000514	0.000514	CcSEcCtD
Methylphenidate—Rash—Doxorubicin—muscle cancer	0.00051	0.00051	CcSEcCtD
Methylphenidate—Dermatitis—Doxorubicin—muscle cancer	0.000509	0.000509	CcSEcCtD
Methylphenidate—Headache—Doxorubicin—muscle cancer	0.000507	0.000507	CcSEcCtD
Methylphenidate—Nausea—Doxorubicin—muscle cancer	0.00048	0.00048	CcSEcCtD
